IDEntifying pAtients with suspicion of infection in the ED who have Low disease severity using midregional proadrenomedullin (MR-proADM) – A pragmatic pivotal randomised controlled trial
IDEntifying pAtients with suspicion of infection in the ED who have Low disease severity using midregional proadrenomedullin (MR-proADM) – A pragmatic pivotal randomised controlled trial. // Clinical Microbiology and Infection. – URL: https://www.sciencedirect.com/science/article/pii/S1198743X26006476?dgcid=rss_sd_all
IDEntifying pAtients with suspicion of infection in the ED who have Low disease severity using midregional proadrenomedullin (MR-proADM) – A pragmatic pivotal randomised controlled trial. Clinical Microbiology and Infection. https://www.sciencedirect.com/science/article/pii/S1198743X26006476?dgcid=rss_sd_all
“IDEntifying pAtients with suspicion of infection in the ED who have Low disease severity using midregional proadrenomedullin (MR-proADM) – A pragmatic pivotal randomised controlled trial.” Clinical Microbiology and Infection.
@article{article40938,
title = {IDEntifying pAtients with suspicion of infection in the ED who have Low disease severity using midregional proadrenomedullin (MR-proADM) – A pragmatic pivotal randomised controlled trial},
journal = {Clinical Microbiology and Infection},
url = {https://www.sciencedirect.com/science/article/pii/S1198743X26006476?dgcid=rss_sd_all}
}
ABSTRACT Background Aspergillus fumigatus can cause life‐threatening infections, primarily treated with azole antifungals. Azole‐resistant A. fumigatus (ARAF) is a major clinical concern. Environmental resistance development is an...
ABSTRACT Background The lipid‐dependent yeast genus Malassezia is composed of skin commensals that can become pathogenic. This genus can cause bloodstream infection in low‐weight preterm neonates and immunocompromised adults. However,...